𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparing the effects of hydrotherapy and land-based therapy on balance in patients with Parkinson's disease: a randomized controlled pilot study

✍ Scribed by Volpe, D.; Giantin, M. G.; Maestri, R.; Frazzitta, G.


Book ID
124052169
Publisher
SAGE Publications
Year
2014
Tongue
English
Weight
452 KB
Volume
28
Category
Article
ISSN
0269-2155

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Controlled pilot study of the effects of
✍ Lauren H. Craig; Anna Svircev; Michael Haber; Jorge L. Juncos 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Abstract The objectives of this study is to examine the effects of neuromuscular therapy (NMT) on motor and nonmotor symptoms in Parkinson's disease (PD). Thirty‐six subjects with PD were randomly assigned to NMT or music relaxation (MR, or active control). Subjects received treatment twice a we

A pilot randomized controlled trial of s
✍ Iracema Leroi; Peter Baker; Pam Kehoe; Emily Daniel; E Jane Byrne 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

## Abstract ## Objective By means of a controlled trial, to investigate the efficacy, tolerability and feasibility of a multi‐component sleep therapy intervention versus basic sleep hygiene education in PD patients with sleep disturbances and their live‐in carers. ## Methods Patient‐carer dyads

The effects of rasagiline on cognitive d
✍ Hasmet A. Hanagasi; Hakan Gurvit; Pınar Unsalan; Hilal Horozoglu; Nese Tuncer; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract Cognitive impairment can occur at all stages of Parkinson's disease. Rasagiline is a selective monoamine oxidase type‐B inhibitor that enhances central dopaminergic transmission. Dopamine is thought to be involved in certain cognitive processes such as working memory. We assessed the ef

A randomized, double-blind, placebo-cont
✍ Fabrizio Stocchi; Rupam Borgohain; Marco Onofrj; Anthony H.V. Schapira; Mohit Bh 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 446 KB 👁 2 views

## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to